RAFT-FORMING DRUG DELIVERY SYSTEM: A FLOATATION-BASED STRATEGY FOR GASTRORETENTION
DOI:
https://doi.org/10.22159/ijcpr.2026v18i2.8029Keywords:
Gastroretentive drug delivery system (GRDDS), Raft-forming system, In situ gelation, Alginic aci, Sodium bicarbonateAbstract
Gastroretentive drug delivery systems (GRDDS) have emerged as a promising strategy to enhance the therapeutic efficacy and bioavailability of orally administered drugs with a narrow absorption window or that are poorly soluble in higher pH environments. Among various approaches, the raft-forming system has garnered significant attention for its simplicity, efficacy, and patient compliance. These systems form a low-density, gel-like "raft" upon contact with gastric fluids, allowing the formulation to float and remain in the stomach for an extended duration. This enhances localized drug action and prevents gastric reflux by acting as a barrier between the stomach and esophagus, particularly benefiting conditions such as GERD, heartburn, and esophagitis. The design involves gel-forming agents like alginic acid and gas-generating components such as sodium bicarbonate, which facilitate in situ gelation and buoyancy. Despite formulation challenges related to pH sensitivity, polymer stability, and gastric motility variations, raft-forming systems offer several advantages, including rapid onset, prolonged activity, ease of administration, and reduced dosing frequency. This review highlights the anatomy and physiology relevant to gastric retention, mechanisms of raft formation, formulation strategies, and potential candidates, emphasizing the system’s growing role in advanced oral drug delivery.
Downloads
References
1. Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming system-an upcoming approach of gastroretentive drug delivery system. J Control Release. 2013;168(2):151-65. doi: 10.1016/j.jconrel.2013.02.028, PMID 23500062.
2. Devi KR. English language teaching in India: a critical review. Int J Pure App Biosci. 2015;3(5):178-83. doi: 10.18782/2320-7051.2119.
3. Nayak A, Maji R, Das B. Gastro retentive drug delivery systems: a review. Asian J Pharm Clin Res. 2010;3(1):2-10.
4. Aparna M, Anju P, Aswini PV. Raft forming system an innovative approach of gastro retentive drug delivery system. Int J Creat Res Thoughts. 2024;12:1-14.
5. Shukla S, Patidar A, Agrawal S, Choukse R. A review on: recent advancement of stomach specific floating drug delivery system. Int J Pharm Biol Arch. 2011;2(6):1561-8.
6. Rathod HJ, Mehta DP, Yadav JS. A review on gastro-resistant drug delivery systems. Pharma Tutor. 2016;4(2):29-40.
7. Nayak AK, Malakar J, Sen KK. Gastroretentive drug delivery technologies: current approaches and future potential. J Pharm Educ Res. 2010;1(2):1-12.
8. Gaur A, Saraswat R. Formulation and evaluation of sodium alginate-based in-situ gel drug delivery system of famotidine. Int J Pharm Innov. 2011;1(1):99-109.
9. Gananarajan G, Pal R. Raft forming gastro retentive drug delivery system a novel approach: a review. World J Pharm Pharm Sci. 2021;10(6):650-9.
10. Andrew A. A review on raft forming drug delivery system mechanism and its significance. AMJ 2022;15(2):336-7. doi: 10.21767/AMJ.2022.3868.
11. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63(3):235-59. doi: 10.1016/S0168-3659(99)00204-7, PMID 10601721.
12. Gurnany E, Singhai P, Soni A, Jain R, Jain SK, Jain A. Gastro retentive drug delivery system a review. J Pharm Res. 2011;4(6):1899-908.
13. Chanda R, Roy A, Bahadur S, Saha S, Das S, Choudhury A. Floating drug delivery: a potential alternative to conventional therapy. Int J Pharm Tech Res. 2010;2(1):49-59.
14. Chaturvedi S, Kumari P, Singh S, Agrawal V. Approaches to increase the gastric residence time: floating drug delivery systems a review. Asian J Pharm Clin Res. 2013;6(3):1-9.
15. Gupta G, Singh AA. A short review on stomach-specific drug delivery system. Int J PharmTech Res. 2012;4(4):1527-45.
16. Kumar A, Verma R. Overview of gastroretentive drug delivery system. J Nat Conscientia. 2011;2(2):423-36.
17. Helliwell M. The use of bioadhesives in targeted delivery within the gastrointestinal tract. Adv Drug Deliv Rev. 1993;11(3):221-51. doi: 10.1016/0169-409X(93)90011-R.
18. Jadi RK, Chinnala KM. A comprehensive review on gastroretentive drug delivery systems. Indo Am J Pharm Sci. 2016;3(1):115-28.
19. Aute SM, Payghan SA, D’Souza AI, Navhkar S, Lad D, Jirole U. Novel approach in gastroretentive drug delivery system: floating microspheres. Int J Pharm Biol Sci Arch. 2014;2(5):9-22.
20. Patel A, Patel V, Patel H, Patel J, Patel H. A review on mucoadhesive microcapsules: novel approach for stomach specific drug delivery. Int J Pharm Res Bio-sci. 2014;3(1):449-65.
21. Vignesh R, Kamaleshwari B, Kaviya G, Kovarthanan M, Raj UM. Innovations in oral drug administration: exploring gastro retentive raft forming system. Int J Pharm Sci. 2024;2(3):289-302. doi: 10.5281/zenodo.10805754.
22. Reddy BV, Navaneetha K, Sandeep P, Deepthi A. Gastroretentive drug delivery system a review. J Glob Trends Pharm Sci. 2013;4(1):1018-33.
23. Singh N, Pandurangan A, Rana K, Anand P, Ahamad A, Tiwari AK. Benzimidazole: a short review of their antimicrobial activities. Int Curr Pharm J. 2012;1(5):110-8. doi: 10.3329/icpj.v1i5.10284.
24. Gunda RK, Vijayalakshmi A. Formulation development and evaluation of gastro retentive drug delivery systems a review. J Pharm Res. 2017;11(2):167-78.
25. Sharma S, Pawar A. Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm. 2006;313(1-2):150-8. doi: 10.1016/j.ijpharm.2006.02.001, PMID 16540268.
26. Rajinikanth PS, Balasubramaniam J, Mishra B. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori. Int J Pharm. 2007;335(1-2):114-22. doi: 10.1016/j.ijpharm.2006.11.008, PMID 17141986.
27. Bhavsar DN. Advances in GRDDS: raft forming system a review. J Drug Delivery Ther. 2012;2(5):123-8. doi: 10.22270/jddt.v2i5.228.
28. Ibrahim HK. A novel liquid effervescent floating delivery system for sustained drug delivery. Drug Discov Ther. 2009;3(4):168-75. PMID 22495603.
29. Prajapati ST, Mehta AP, Modhia IP, Patel CN. Formulation and optimisation of raft-forming chewable tablets containing H2 antagonist. Int J Pharm Investig. 2012;2(4):176-82. doi: 10.4103/2230-973X.106988, PMID 23580933.
30. Kapadia CJ, Mane VB. Raft-forming agents: antireflux formulations. Drug Dev Ind Pharm. 2007;33(12):1350-61. doi: 10.1080/03639040701385691, PMID 18097809.
31. Shah S, Upadhyay P, Shah J. In situ gel: a novel approach of gastroretentive drug delivery. Asian J Biomed Pharm Sci. 2012;2(8):1-8.
32. Ali J, Ahuja A, Baboota S, Qureshi M. Formulation strategy for low absorption window antihypertensive agent. Indian J Pharm Sci. 2007;69(3):360-4. doi: 10.4103/0250-474X.34543.
33. Suresh S, Bhaskaran S. Nasal drug delivery: an overview. Indian J Pharm Sci. 2005;67(1):19-25.
34. Gananarajan G, Pal R. Raft forming gastroretentive drug delivery system a novel approach. World J Pharm Pharm Sci. 2021;10(6):650-9.
35. Kubo W, Konno Y, Miyazaki S, Attwood D. In situ gelling pectin formulations for oral sustained delivery of paracetamol. Drug Dev Ind Pharm. 2004;30(6):593-9. doi: 10.1081/DDC-120037490, PMID 15285332.
36. Schild HG. Poly(N-isopropylacrylamide): experiment, theory and application. Prog Polym Sci. 1992;17(2):163-249. doi: 10.1016/0079-6700(92)90023-R.
37. Sawhney AS, Pathak CP, Hubbell JA, Hill JL, Desai NP. Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled release carriers. US Patent 5410016A; 1995.
38. Rathod H, Patel V, Modasia M. In situ a novel approach of gastroretentive drug delivery. Int J Pharm Life Sci. 2010;1(6):440-5.
39. Teaima M, Abdelmonem R, Saady M, El-nabarawi M, Shoman NA. Comprehensive overview on recent updates gastroretentive of raft-forming systems: a review. Int J App Pharm. 2022;14(3):40-8. doi: 10.22159/ijap.2022v14i3.44098.
40. Bineesha KB, Dharan S, Abraham S, Panicker JT, James JE. Gastroretentive raft forming drug delivery: a novel expansion: a review. Int J Pharm Pharm Res. 2019;15(2):200-12.
41. Miyazaki S, Aoyama H, Kawasaki N, Kubo W, Attwood D. In situ-gelling gellan formulations as vehicles for oral drug delivery. J Control Release. 1999;60(2-3):287-95. doi: 10.1016/S0168-3659(99)00084-X, PMID 10425334.
42. Gulkari VD, Bakhle SS, Yelane LS. Development and evaluation of ofloxacin floating tablets using natural polymer: Sterculia foetida Linn. gum. Int J Pharm Pharm Sci. 2016;8(5):356-60.
43. Maheswaran A, Padmavathy J, Nandhini V, Saravanan D, Angel P. Formulation and evaluation of floating oral in situ gel of diltiazem hydrochloride. Int J App Pharm. 2016;9(1):50. doi: 10.22159/ijap.2017v9i1.15914.
44. Kashyap N, Viswanad B, Sharma G, Bhardwaj V, Ramarao P, Ravi Kumar MN. Design and evaluation of biodegradable biosensitive in situ gelling system for pulsatile delivery of insulin. Biomaterials. 2007;28(11):2051-60. doi: 10.1016/j.biomaterials.2007.01.007, PMID 17240443.
45. Chandrashekar G, Udupa N. Biodegradable injectable implant systems for long term drug delivery using poly (lactic-co-glycolic) acid copolymers. J Pharm Pharmacol. 1996;48(7):669-74. doi: 10.1111/j.2042-7158.1996.tb03948.x, PMID 8866326.
46. Teaima MH, Abdel Hamid MM, Shoman NA, Jasti BR, El-Nabarawi MA, Yasser M. Formulation characterization and comparative pharmacokinetic study of bupropion floating raft system as a promising approach for treating depression. J Pharm Sci. 2020;109(11):3451-61. doi: 10.1016/j.xphs.2020.08.011, PMID 32835701.
47. Boddupalli BM, Mohammed ZN, Nath RA, Banji D. Mucoadhesive drug delivery system: an overview. J Adv Pharm Technol Res. 2010;1(4):381-7. doi: 10.4103/0110-5558.76436, PMID 22247877.
48. More S, Gavali K, Doke O, Kasgawade P. Gastroretentive drug delivery system. J Drug Delivery Ther. 2018;8(4):4. doi: 10.22270/jddt.v8i4.1788.
49. Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming system-an upcoming approach of gastroretentive drug delivery system. J Control Release. 2013;168(2):151-65. doi: 10.1016/j.jconrel.2013.02.028, PMID 23500062.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Sama Sulaika.M; Gomathi. J
This work is licensed under a Creative Commons Attribution 4.0 International License.